The percentage of new drug candidates that are highly potent is rising, driving the need for additional manufacturing capacity for highly potent compounds. However, producing these challenging molecules is a complex process. Specialised facilities, equipment and highly skilled personnel are required.
The increasing focus on highly potent active pharmaceutical ingredients (HPAPIs) in pharmaceutical development pipelines has led to a growing requirement for the capability to safely handle and contain these hazardous ingredients.
Manufacturing Chemist Live will put professionals working in the pharmaceutical industry ahead of the curve. The two-day conference will address key pharmaceutical HPAPI processing from regulatory and compliance to operational.